FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014765302> ?p ?o ?g. }

• W2014765302 endingPage "1192" @default.
• W2014765302 startingPage "1187" @default.
• W2014765302 abstract "Oral lichen planus (OLP) is a T-cell-mediated inflammatory disease. Interleukin (IL)-8 is a pro-inflammatory cytokine of host response to injury and inflammation.To investigate whether serum IL-8 level was a more sensitive marker than serum IL-6 level in monitoring the disease activity of OLP and to assess whether IL-8 was a useful serum marker in evaluating the therapeutic effects of levamisole on OLP patients.In this study, we used a solid phase, two-site sequential chemiluminescent immunometric assay to determine the baseline serum levels of IL-6 and IL-8 in 158 patients with OLP, nine patients with traumatic ulcers (TU) and 54 normal control subjects. Some OLP patients with the serum IL-6 or IL-8 levels higher than the upper limit of normal serum concentration were treated with levamisole for 0.5-6.0 months and their serum IL-6 and IL-8 levels were measured after treatment.We found that 28% (44 of 158) OLP, 28% (40 of 142) erosive OLP (EOLP), and 25% (four of 16) nonerosive OLP (NEOLP) patients had a serum IL-6 level greater than the upper normal limit of 4.7 pg mL(-1). In contrast, 63% (99 of 158) OLP, 63% (90 of 142) EOLP and 56% (nine of 16) NEOLP patients had a serum IL-8 level greater than the upper normal limit of 8.7 pg mL(-1). In some OLP patients with the serum IL-6 or IL-8 levels higher than the upper limit of normal serum concentration, treatment with levamisole for a period of 0.5-6.0 months could significantly reduce the mean serum IL-6 level from 14.3 +/- 1.9 pg mL(-1) to 3.2 +/- 0.6 pg mL(-1) (P < 0.001) and could significantly reduce the mean serum IL-8 level from 95.8 +/- 17.1 pg mL(-1) to 14.8 +/- 5.8 pg mL(-1) (P < 0.001).Because measurement of the serum IL-8 level can detect more OLP patients with an abnormal serum level than measurement of the serum IL-6 level (63% vs. 28%), we conclude that serum IL-8 level is a more sensitive marker than serum IL-6 level in monitoring the disease activity of OLP. Levamisole can modulate both the serum IL-6 and IL-8 levels in OLP patients. IL-8, like IL-6, is also a useful serum marker in evaluating the therapeutic effects of levamisole on OLP patients." @default.
• W2014765302 created "2016-06-24" @default.
• W2014765302 creator A5038738932 @default.
• W2014765302 creator A5054820201 @default.
• W2014765302 creator A5075967308 @default.
• W2014765302 creator A5082051948 @default.
• W2014765302 date "2005-06-01" @default.
• W2014765302 modified "2023-10-11" @default.
• W2014765302 title "Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus" @default.
• W2014765302 cites W168027546 @default.
• W2014765302 cites W1768364851 @default.
• W2014765302 cites W1951540415 @default.
• W2014765302 cites W1976518258 @default.
• W2014765302 cites W1986738173 @default.
• W2014765302 cites W1987136866 @default.
• W2014765302 cites W1999148504 @default.
• W2014765302 cites W2003658781 @default.
• W2014765302 cites W2005976907 @default.
• W2014765302 cites W2016250676 @default.
• W2014765302 cites W2018309547 @default.
• W2014765302 cites W2020233964 @default.
• W2014765302 cites W2031915976 @default.
• W2014765302 cites W2034883447 @default.
• W2014765302 cites W2035462686 @default.
• W2014765302 cites W2070280267 @default.
• W2014765302 cites W2070461648 @default.
• W2014765302 cites W2074906410 @default.
• W2014765302 cites W2084664449 @default.
• W2014765302 cites W2086812919 @default.
• W2014765302 cites W2087150574 @default.
• W2014765302 cites W2090714000 @default.
• W2014765302 cites W2094660628 @default.
• W2014765302 cites W2096501831 @default.
• W2014765302 cites W2097314820 @default.
• W2014765302 cites W2112336536 @default.
• W2014765302 cites W2118927199 @default.
• W2014765302 cites W2132456124 @default.
• W2014765302 cites W2149122802 @default.
• W2014765302 cites W2172004348 @default.
• W2014765302 doi "https://doi.org/10.1111/j.1365-2133.2005.06497.x" @default.
• W2014765302 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15948980" @default.
• W2014765302 hasPublicationYear "2005" @default.
• W2014765302 type Work @default.
• W2014765302 sameAs 2014765302 @default.
• W2014765302 citedByCount "47" @default.
• W2014765302 countsByYear W20147653022012 @default.
• W2014765302 countsByYear W20147653022013 @default.
• W2014765302 countsByYear W20147653022014 @default.
• W2014765302 countsByYear W20147653022015 @default.
• W2014765302 countsByYear W20147653022016 @default.
• W2014765302 countsByYear W20147653022017 @default.
• W2014765302 countsByYear W20147653022018 @default.
• W2014765302 countsByYear W20147653022019 @default.
• W2014765302 countsByYear W20147653022020 @default.
• W2014765302 countsByYear W20147653022021 @default.
• W2014765302 countsByYear W20147653022022 @default.
• W2014765302 countsByYear W20147653022023 @default.
• W2014765302 crossrefType "journal-article" @default.
• W2014765302 hasAuthorship W2014765302A5038738932 @default.
• W2014765302 hasAuthorship W2014765302A5054820201 @default.
• W2014765302 hasAuthorship W2014765302A5075967308 @default.
• W2014765302 hasAuthorship W2014765302A5082051948 @default.
• W2014765302 hasBestOaLocation W20147653021 @default.
• W2014765302 hasConcept C11988809 @default.
• W2014765302 hasConcept C126322002 @default.
• W2014765302 hasConcept C203014093 @default.
• W2014765302 hasConcept C2776201145 @default.
• W2014765302 hasConcept C2778690821 @default.
• W2014765302 hasConcept C2781325985 @default.
• W2014765302 hasConcept C71924100 @default.
• W2014765302 hasConcept C74172505 @default.
• W2014765302 hasConcept C90924648 @default.
• W2014765302 hasConceptScore W2014765302C11988809 @default.
• W2014765302 hasConceptScore W2014765302C126322002 @default.
• W2014765302 hasConceptScore W2014765302C203014093 @default.
• W2014765302 hasConceptScore W2014765302C2776201145 @default.
• W2014765302 hasConceptScore W2014765302C2778690821 @default.
• W2014765302 hasConceptScore W2014765302C2781325985 @default.
• W2014765302 hasConceptScore W2014765302C71924100 @default.
• W2014765302 hasConceptScore W2014765302C74172505 @default.
• W2014765302 hasConceptScore W2014765302C90924648 @default.
• W2014765302 hasIssue "6" @default.
• W2014765302 hasLocation W20147653021 @default.
• W2014765302 hasLocation W20147653022 @default.
• W2014765302 hasOpenAccess W2014765302 @default.
• W2014765302 hasPrimaryLocation W20147653021 @default.
• W2014765302 hasRelatedWork W1646653418 @default.
• W2014765302 hasRelatedWork W1971944195 @default.
• W2014765302 hasRelatedWork W2029595088 @default.
• W2014765302 hasRelatedWork W2066137140 @default.
• W2014765302 hasRelatedWork W2085673832 @default.
• W2014765302 hasRelatedWork W2085829142 @default.
• W2014765302 hasRelatedWork W2090594461 @default.
• W2014765302 hasRelatedWork W2090714000 @default.
• W2014765302 hasRelatedWork W2133618989 @default.
• W2014765302 hasRelatedWork W2912786107 @default.
• W2014765302 hasVolume "152" @default.
• W2014765302 isParatext "false" @default.

• next